Experts Recommend Requiring Randomized Trials For Flow Diverter PMAs
This article was originally published in The Gray Sheet
Executive Summary
FDA's Neurological Devices Panel says sponsors should be required to conduct randomized controlled trials for aneurysm treatment devices such as flow diverters and should only be allowed to use performance goal studies as a last resort to support approval.